Navigation Links
Is There Any Clinical Benefit to Staying on a Failing Regimen?

protease inhibitors and ritonavir-boosted protease inhibitors. 43% of patients were receiving two nucleoside analogues and a single protease inhibitor, while 39% were receiving a regimen containing drugs from all three classes.

One genotypic resistance test was used to define the baseline resistance pattern in 75 patients; two genotypic tests defined resistance in 23, and three tests defined resistance in the remaining 12 patients. Thymidine analogue mutations (TAMS) accounted for 75% of all DRGs and the mutation was primarily at the 184V codon. The evolution of resistance was then evaluated between the baseline test (t0) and a subsequent test a median of six months later (t1) (range 2-28 months).

From the time of the first genotypic test to the second, 77% of patients acquired one or more extra International AIDS Society (IAS)-defined drug resistance mutations, with an overall six month increase of 1.96 mutations. Using the Rega interpretation system, this meant an overall average loss of 1.25 active antiretroviral drugs per each six-month period that a patient remained on a failing regimen (this includes all ARVs available in January 2006). The authors note though that depending on the drug regimen followed and the extent of resistance, it cannot be assumed that the accumulation of mutations is limitless.

In this same time period, the mean CD4 cell count remained relatively stable at ~280 cells/mm3 with an estimated loss of 9.79 cells/mm3 while viral load rose by approximately 0.14 log10 copies/mL, resulting in a mean viral load of 3.87 log10 copies/mL.

The prevalence of resistance to the failing regimen at the time of the first resistance test was not predictive of the accumulation of drug resistance mutations when an adjusted analysis was performed. The main predictor of change in the number of IAS-defined mutations over time was an inverse association with CD4 cell count nadir. Those patients in the cohort with re
'"/>




Page: 1 2 3

Related medicine news :

1. Could There Be A Link Between Famine and Breast Cancer ?
2. Can There Be A Diabetes Type III?
3. Diabetic Amputation May Reduce If Free Screenings Are There
4. Hospital Says There Is Time but Baby Decides Otherwise
5. WHO’s asking :Is There Light At The End Of The Tunnel In Tajikistan
6. There is light at the end of the blind tunnel: prosthetic retinal cells offer hope!
7. Is There A Strong Link Between Fluoride In Tap Water And Bone Cancer?
8. Is There a Connection between Hearing loss and High-speed Dental Tools?
9. Clinical trials need to be more frank
10. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
11. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: There Any Clinical Benefit Staying Failing Regimen

(Date:4/24/2015)... 2015 Lowcostcarinsuranceprice.com has released a new ... auto insurance for senior citizens . , Senior ... does not mean that they cannot find affordable coverage. ... can find the right coverage for their cars at ... like http://lowcostcarinsuranceprice.com/ provides free leads from various ...
(Date:4/24/2015)... Integrative Therapeutics has introduced two ... and cognition. , A unique combination of herbs ... Wellness Flavonoid Complex apart from other antioxidant supplements. ... to support antioxidation versus the use of single ... tea extract, Resveratrol, Alpha-Glycosyl Isoquercitrin, and Coenzyme Q10 ...
(Date:4/24/2015)... With years of experience providing ... proud to be partnered with a veterinary college where ... year. This partnership has brought new payment options for ... After providing an in-house payment plan for many years, ... wanted to increase financing options available to avoid having ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 IntelliSoft ... provider enrollment and contract management software, featured IntelliCred ... Medical Staff Services Annual Educational Conference (IAMSS) ... Resort in Oak Brook, Illinois. , Notable improvements ... , Contract Linking: A ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive Data event ... suppliers, content providers, associations and government bodies. From industry ... see them converge in Berlin. This year’s start-up competition ... companies currently at the forefront of Europe’s Silicon Valley ... centric products, ParkTAG are one of the first social ...
Breaking Medicine News(10 mins):Health News:Low Cost Auto Insurance Quotes for Senior Citizens 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:IntelliSoft Group Version 14.2 of IntelliCred featured at the Illinois Association of Medical Staff Services Annual Educational Conference 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3
... American Heart Association extend their sympathy to the family and friends ... , "It,s a shame when someone his age dies so ... "Although we don,t know all the details of the situation, ... react quickly. Our thoughts and prayers are with the Jackson ...
... Wash., June 25 Verathon Inc., maker of ... announced today the appointment of Kendall Stever as ... will include management and oversight of the Company,s ... functions for company headquarters in Washington State, taxation, ...
... finds , THURSDAY, June 25 (HealthDay News) -- Consumption of ... associated with it. Worldwide, one in 25 deaths and 5 ... are related to alcohol, according to a new study. , ... of about 1.6 gallons (6.2 liters) of pure ethanol a ...
... ... Cases, , ... CO (PRWEB) June 25, 2009 -- Two grocery checkers--a 28-year-old female triathlete and a ... are identical. Which employee will return to work sooner? Is there anything you can ...
... In a 6-5 decision in Richmond Medical Center v. ... ban on partial birth infanticide -- a law that mirrors the ... United for Life (AUL) provided litigation support to the ... Virginia,s law. In addition, AUL Senior Counsel Clarke Forsythe assisted ...
... there is no cure for HIV/AIDS. However, major advances ... with HIV/AIDS. For example, Dr. Michael Hall has revolutionized ... diseases. He envisions a synergy between the evolution of ... the Hall Longevity Clinic Lifecard , ...
Cached Medicine News:Health News:American Heart Association Extends Sympathy to Family of Singer Michael Jackson 2Health News:Verathon Inc. Appoints Kendall Stever as Chief Financial Officer 2Health News:Alcohol-Related Ills Increasing Worldwide 2Health News:Alcohol-Related Ills Increasing Worldwide 3Health News:MDGuidelines Offers New Predictive Modeling Feature 2Health News:MDGuidelines Offers New Predictive Modeling Feature 3Health News:MDGuidelines Offers New Predictive Modeling Feature 4Health News:Americans United for Life Applauds Fourth Circuit Protecting Women and Children by Upholding Virginia Partial Birth Abortion Statute 2Health News:Dr. Hall Revolutionizes National HIV Testing Day 2
(Date:4/24/2015)... 2015  Novartis Pharmaceuticals Corporation (NPC) has been named the ... row on the annual DiversityInc Top 50 Companies for Diversity ... Companies for Diversity on April 23 at an awards ceremony ... ranked second on the DiversityInc Top 10 Companies for Recruitment ... Resource Groups list. David Epstein , ...
(Date:4/24/2015)... , April 24, 2015 Hospira, Inc. ... the development of biosimilar therapies, spoke about the importance ... the European Generics Association (EGA) annual European Biosimilars Group ... The company also announced the publication of a pivotal ... achieving the full promise of biosimilars." ...
(Date:4/23/2015)... (NYSE: RMD ) today announced results for its ... was $422.5 million, a 6 percent increase compared to ... increase on a constant currency basis).  Net income was ... the quarter ended March 31, 2014.  Diluted earnings per ... 2 percent compared to the quarter ended March 31, ...
Breaking Medicine Technology:Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 11ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 12ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015 13
... Dec. 20, 2010 Ambit Biosciences (Ambit), ... trials for two products AC430, a selective Janus Kinase ... The Phase I trial for AC430 is a ... trial in healthy volunteers.  AC430 will be administered orally ...
... Center for Business Intelligence (CBI) has been recognized as a ... was awarded recently to Kathleen Y. Coffey, CBI President, by ... Boston Park Plaza Hotel.   The Top ... $47.5B in annual revenue and $202,664 employees. Over 500 women ...
Cached Medicine Technology:Ambit Biosciences Initiates Two Phase I Clinical Trials 2The Center for Business Intelligence (CBI) Receives Top 100 Women-Led Businesses Award 2
... Varicella-Zoster Virus (VZV) IgG Enzyme-Linked Immunosorbent ... and quantitative determination of IgG antibody to ... specimens may be used for the determination ... convalescent, may be used to demonstrate seroconversion ...
... Inc. Mumps IgG ELISA test system is ... IgG antibody in human serum. When performed ... this test, together with other clinical information, ... status, and/or aid in the diagnosis of ...
... Mumps IgM Enzyme-Linked Immunosorbent Assay ... qualitative detection of IgM antibody ... for the determination of immunological ... this kit have not been ...
The CALBIOTECH, INC. (CBI), Mumps IgM ELISA tests system is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Mumps in human serum or plasma....
Medicine Products: